# LARIN 1/20
> **ANDA202995** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2013-12-04
## Drug
- **FDA Application Number:** ANDA202995
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LARIN 1/20
- **Generic name:** NORETHINDRONE ACETATE/ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL-21
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **Manufacturer:** Dr.Reddy's Laboratories Inc.
- **First approval:** 2013-12-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202995)
---
*AI Analytics · CC0 1.0*